Danny Yeung

Since 2014, Danny Yeung has been transforming healthcare with Prenetics, steering the company from an early pioneer in genetic testing into a global consumer health powerhouse. Originally from the US, he started working as a telemarketer aged 15, but his first foray into entrepreneurship was franchising Hong Kong dessert chain Hui Lau Shan in the US, after which he ran a hospitality furniture company in Macau. He then founded group buying website Ubuyibuy, only to sell it to Groupon after just six months.

Prenetics has been his biggest success thus far. It first launched CircleDNA, which sells affordable at-home test kits that detect disease risk, food sensitivities, personality and behavioural traits, allowing people to take their health into their own hands. In 2020, it rolled out Project Screen by Circle, an accessible Covid-19 test that was famously adopted by football’s English Premier League. The company was a financial high-flyer from the outset, becoming Hong Kong’s first listed unicorn when it debuted on Nasdaq in 2022.

In 2023, Yeung launched Insighta, an early cancer detection joint venture with renowned scientist Dennis Lo, before completing the strategic sale of Prenetics’ stake to Chinese tech giant Tencent in early 2026. That move streamlined the group to concentrate on consumer longevity and its flagship venture: IM8, the science-backed wellness brand co-founded in 2024 with football icon and entrepreneur David Beckham.

Pivoting from diagnostics to wellness, Yeung engineered one of the industry’s fastest scale-ups by expanding IM8 across 43 countries. Backed by a historic US$1 billion non-dilutive financing commitment from General Catalyst in 2026, he drove the subsidiary to a US$200 million recurring revenue run rate within 19 months.